MA-DESKTOP-METAL
6.10.2021 13:32:09 CEST | Business Wire | Press release
As Desktop Metal (NYSE: DM) continues to advance Additive Manufacturing 2.0 (AM 2.0) to reshape the future of manufacturing with mass production and turnkey AM solutions, the company is seeing growing European demand for metal binder jetting, including the Shop System™, the world’s first metal binder jetting system designed for machine shops.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211006005343/en/
Since volume shipments of the Shop System began in the fourth quarter of 2020, the system has experienced strong adoption among leading global businesses looking to leverage high-quality binder jetting technology to print end-use metal parts in volumes and at costs unattainable through either conventional manufacturing or legacy additive manufacturing processes. In particular, the Shop System is gaining momentum with European customers, with robust demand from manufacturers across countries such as France, Finland, Germany, Greece, Italy, Portugal, Spain, the Netherlands, and the United Kingdom.
"We are now at an inflection point where mid- and high-volume production of end-use metal parts through AM is one of the most transformational opportunities for manufacturers,” said Pierre-Victor Sabatier, VP of Sales - EMEA at Desktop Metal. “With this backdrop, it's no surprise that there is accelerating interest in binder jetting here in Europe. We are seeing growing adoption of the Shop System as plant operators, engineers, and production managers realize this solution effectively complements their conventional manufacturing operations with reliable, accessible, and flexible batch production of complex and detailed parts at low costs. With the industry shifting to adapt to supply chain challenges and renewed requests for local manufacturing, Desktop Metal is well positioned to answer the impressive demand we are seeing for production metal AM technologies in Europe and beyond.”
The Shop System is designed to bring metal AM to machine and job shops with an affordable, turnkey solution that achieves exceptional surface finish parts with rich feature detail at speeds up to 10 times those of legacy powder bed fusion AM technologies. With the Shop System, users can print end-use metal parts for use in a variety of industries spanning automotive, oil & gas, industrial machinery, and consumer products.
Leading European Companies See the Benefits of the Shop System for Mid-Volume Manufacturing
-
Cosmind s.r.l.
, based in Italy, specializes in the processing of precision sheet metal and mechanical carpentry in the naval, railway, aeronautical, and electronic industries.
“For Cosmind, continuous and constant growth, the improvement of production processes, quality, competitiveness and technological innovation are the fundamental points of the company vision,” said Marco Donisi, COO and Plant Manager, Cosmind s.r.l. “Particular emphasis has been placed on technological innovation with the implementation of new technologies in the additive manufacturing sector. The choice of Desktop Metal technology is the right combination of market diversification and technological innovation. We are convinced that the Desktop Metal Shop System technology will significantly contribute to a turning point in the mechanical sector. With this in mind, we have invested in the creation of a technological hub offering ourselves as a 3D printing service with different technologies and materials available to our customers.”
-
EdilCAM Sistemi
(ECS), based in Italy, specializes in seismic retrofitting of buildings and civil structures.
“With Desktop Metal’s Shop System, ECS has found a unique and powerful production method that has widened the design boundaries for our company’s patented system, Active Tensioner Multi Material,” said Alessandro Vari, CEO, EdilCAM Sistemi. “Offering extraordinary performance compared to already existing technologies, ECS can also introduce binder jetting to new areas like bridges and viaducts, but also in monuments and historic buildings. Thanks to Desktop Metal’s binder jetting solutions and ECS’s twenty-year history of seismic strengthening, our company can be the first to introduce metal binder jetting in seismic retrofitting.”
-
Officine Piki
, based in Italy, specializes in stainless steel processing.
“The Desktop Metal Shop System presents an important opportunity for the future of additive manufacturing, especially with prototyping, low-cost production, and the ability to make metal parts which cannot be realized with traditional manufacturing methods due to geometries and internal cavities,” said Davide Vitali, General Manager, Officine Piki. “We also believe in the sustainability of [the system’s] 3D printing process thanks to less use of raw materials resulting in a reduction of waste and recycling of materials, reduction of energy used for production, lower use of water than any other production system, no use of chemical emulsions that must be disposed of, and the opportunity for printing with sustainable materials, such as recycled wood dust.”
-
Poral
, based in France, is a leading powder metallurgy supplier, specializing in technical components across automotive, aerospace, chemical processing, and more.
“We started to investigate metal additive manufacturing some time ago, but we were waiting for the right solution for our company and customers. We needed a solution that would offer all of the benefits of 3D printing, with greater productivity and reduced costs,” said Denis Pugnet, CEO, Poral. “The Shop System allows us to provide complementary solutions to our customers, enabling them to innovate and save both time and money. It's also a great business development tool for us, attracting new opportunities and positioning us as a leading player in the local manufacturing and Industry 4.0 fields. We already see some big projects coming to us and we anticipate huge growth in the demand for metal binder jetting parts in the coming months.”
-
VTT Technical Research Centre of Finland (VTT)
, based in Finland, is one of Europe’s leading research institutions, helping to advance the utilization and commercialization of research and technology around the world.
“The development of metal binder jetting expands the applications of additive manufacturing to an even wider range of new applications that have not previously been commercially meaningful,” said Pasi Puukko, Head of VTT’s research team. “In particular, [Desktop Metal’s Shop System] binder jetting technology is better suited for applications where larger series are needed. With this technology, the range of materials is also expanding to new areas.”
The Shop System - Affordable, Batch Production of High-Quality Metal Parts
Featuring the most advanced single pass print engine in the binder jetting market, the Shop System offers a turnkey solution for producing complex, end-use metal parts in a fraction of the time and cost of conventional manufacturing and comparably priced legacy AM technologies. The Shop System includes all the equipment machine shops need to begin binder jetting—from printing through sintering—and is designed to scale throughput with a range of build volume configurations. In addition, Desktop Metal software for build preparation and sintering simulation, in combination with metal powders and process parameters optimized to deliver exceptional part quality and repeatability, make it easy for businesses to get up and running with binder jetting in days instead of weeks or months.
Key benefits of the Shop System include:
-
Easy to use and operate.
Designed with the modern machine shop in mind, the Shop System produces parts at the push of a button through its easy-to-use software interface. It features engineered powders and default processing parameters optimized to deliver exceptional quality and ensure repeatability without the need for extensive third party materials qualification or process development. The use of software-generated hand-removable sintering setters eliminates the need for costly and labor-intensive post-processing steps.
-
High productivity and superior print quality.
Featuring variable build sizes up to 16L and a high-speed, single pass print carriage, the Shop System produces end-use metal parts up to 10 times the speed and at a fraction of the cost of legacy additive manufacturing technologies, amplifying existing output with up to hundreds of complex metal parts printed per day, with mechanical properties exceeding industry standards. With speeds up to 800 cc/hour, the Shop System enables batches of tens or hundreds of complex printed parts in as little as five hours.
- Rich feature detail with exceptional surface finish. Businesses can print dense, complex metal parts with incredibly fine feature detail and surface finishes as low as four-micron roughness average (Ra) out of the furnace. Leveraging an advanced single pass printhead, 1600 native DPI, the Shop System delivers 400 percent the resolution of legacy binder jetting systems. Reliable print quality is enabled by the 5x nozzle redundancy on the printhead — 25 percent higher redundancy than comparable binder jetting systems.
To learn more about the Shop System, visit www.desktopmetal.com/products/shop .
About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum and named to MIT Technology Review’s list of 50 Smartest Companies. For more information, visit www.desktopmetal.com .
Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211006005343/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
